RadNet, Inc. $RDNT Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in shares of RadNet, Inc. (NASDAQ:RDNT) by 18.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,004 shares of the medical research company’s stock after purchasing an additional 8,737 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in RadNet were worth $4,192,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Farther Finance Advisors LLC boosted its stake in RadNet by 1,086.5% during the third quarter. Farther Finance Advisors LLC now owns 439 shares of the medical research company’s stock worth $33,000 after buying an additional 402 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of RadNet during the 2nd quarter worth approximately $35,000. Salomon & Ludwin LLC acquired a new stake in RadNet in the 3rd quarter valued at approximately $37,000. State of Wyoming purchased a new stake in RadNet in the second quarter valued at approximately $58,000. Finally, Jones Financial Companies Lllp lifted its stake in RadNet by 563.4% during the first quarter. Jones Financial Companies Lllp now owns 1,705 shares of the medical research company’s stock worth $85,000 after purchasing an additional 1,448 shares in the last quarter. Institutional investors and hedge funds own 77.90% of the company’s stock.

Analysts Set New Price Targets

RDNT has been the subject of a number of research reports. Raymond James Financial reaffirmed a “strong-buy” rating on shares of RadNet in a research note on Thursday, December 18th. B. Riley raised their target price on RadNet from $71.00 to $87.00 and gave the company a “buy” rating in a report on Monday, December 1st. UBS Group set a $92.00 price target on shares of RadNet in a research note on Friday, January 9th. Weiss Ratings reissued a “sell (d-)” rating on shares of RadNet in a research note on Monday, December 29th. Finally, The Goldman Sachs Group upgraded shares of RadNet to a “buy” rating in a report on Tuesday, December 16th. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $90.33.

Insider Buying and Selling

In related news, CAO Mital Patel sold 25,000 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $76.06, for a total value of $1,901,500.00. Following the transaction, the chief accounting officer owned 205,138 shares in the company, valued at $15,602,796.28. The trade was a 10.86% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders have sold 50,000 shares of company stock valued at $3,902,254 in the last quarter. Insiders own 5.60% of the company’s stock.

RadNet Stock Down 2.2%

Shares of NASDAQ:RDNT opened at $72.50 on Wednesday. RadNet, Inc. has a fifty-two week low of $45.00 and a fifty-two week high of $85.84. The firm’s 50 day moving average price is $75.70 and its 200 day moving average price is $72.38. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.82. The stock has a market cap of $5.59 billion, a price-to-earnings ratio of -426.45 and a beta of 1.51.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Monday, November 10th. The medical research company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.03). The company had revenue of $522.87 million during the quarter, compared to analysts’ expectations of $494.19 million. RadNet had a negative net margin of 0.65% and a positive return on equity of 2.52%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 earnings per share. As a group, equities research analysts predict that RadNet, Inc. will post 0.56 earnings per share for the current fiscal year.

RadNet Profile

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.